Skip to main content
Premium Trial:

Request an Annual Quote

Halo Diagnostics, Ikonopedia Partner to Provide Genetic Testing for Breast Cancer

NEW YORK – Halo Diagnostics and imaging company Ikonopedia announced on Monday that they are partnering to provide genetic testing for breast cancer to improve early detection.

Under the partnership, Ikonopedia's mammography software and radiology reporting will be integrated with Halo's genetic laboratory and precision diagnostic software services, the firms said in a statement. Ikonopedia's risk assessment tool will identify patients for hereditary testing, and physicians will be able to order Halo's Women's Health Precision Diagnostic suite, which combines imaging, a risk calculator, and genetic test results to determine which patients may benefit from additional breast cancer screening and management, the companies said. 

Through the partnership, radiology centers will have access to Halo's services, including its hereditary gene panel and polygenic risk score, as well as integrated genetic counseling and a laboratory liaison who will work onsite at the radiology center. Centers will also have automated lab ordering and eligibility checks, along with a precision diagnostic report that includes follow-up imaging for patients with a high risk of breast cancer, Halo said. 

The integration is expected to increase compliance for follow-up imaging by 40 percent, the companies said.

"Our combined solution will save lives by improving early detection through fast, accurate diagnosis and personalized care," Brian Axe, Halo's founder and chief product officer, said in a statement. 

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.